Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
American Financial Group
AFG
$12.1B
| $20.5M | 0.02% |
323,000
-33,951
| -10% | -$2.19M |
|
802
Sterling Infrastructure
STRL
$16.9B
| $20.5M | 0.02% |
1,956,600
-131,000
| -6% | -$1.21M |
|
803
Everest Group
EG
$14B
| $20.5M | 0.02% |
99,325
+60,320
| +155% | +$11.7M |
|
804
PagerDuty
PD
$932M
| $20.4M | 0.02% |
713,800
+212,600
| +42% | +$5.13M |
|
|
P
805
Everpure Inc
P
$39B
| $20.4M | 0.02% |
1,178,375
-1,152,863
| -49% | -$17.3M |
|
|
BRKL
806
DELISTED
Brookline Bancorp
BRKL
| $20.4M | 0.02% |
2,023,112
-76,028
| -4% | -$759K |
|
807
Gilat Satellite Networks
GILT
$886M
| $20.3M | 0.02% |
3,190,749
+127,520
| +4% | +$981K |
|
808
Cracker Barrel
CBRL
$1.31B
| $20.3M | 0.02% |
183,132
-109,700
| -37% | -$10.9M |
|
809
Cavco Industries
CVCO
$4.67B
| $20.3M | 0.02% |
105,245
-37,954
| -27% | -$6.22M |
|
810
Fiverr
FVRR
$324M
| $20.3M | 0.02% |
274,400
+254,900
| +1,307% | +$13.1M |
|
811
Moderna
MRNA
$25.4B
| $20.3M | 0.02% |
+315,400
| New | +$17.3M |
|
812
eGain
EGAN
$206M
| $20.1M | 0.02% |
1,810,033
+230,912
| +15% | +$2.1M |
|
|
WMGI
813
DELISTED
Wright Medical Group Inc
WMGI
| $20.1M | 0.02% |
676,407
+384,100
| +131% | +$11.2M |
|
|
QIWI
814
DELISTED
QIWI PLC
QIWI
| $20.1M | 0.02% |
1,160,351
-838,000
| -42% | -$11.4M |
|
815
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $20M | 0.02% |
1,012,419
-1,000
| -0.1% | -$19.9K |
|
816
CVB Financial
CVBF
$4.08B
| $19.9M | 0.02% |
1,063,400
-264,200
| -20% | -$5.04M |
|
817
WEC Energy
WEC
$35.9B
| $19.9M | 0.02% |
226,975
-743,415
| -77% | -$67.1M |
|
818
IMAX
IMAX
$2.92B
| $19.8M | 0.02% |
1,769,800
+428,300
| +32% | +$5.01M |
|
819
Orthofix Medical
OFIX
$415M
| $19.8M | 0.02% |
619,369
+158,900
| +35% | +$5.27M |
|
|
LSXMK
820
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $19.8M | 0.02% |
741,580
-476,209
| -39% | -$12.3M |
|
821
Leggett & Platt
LEG
$1.32B
| $19.8M | 0.02% |
562,500
+23,250
| +4% | +$721K |
|
822
Grand Canyon Education
LOPE
$3.79B
| $19.8M | 0.02% |
218,387
+136,300
| +166% | +$12.1M |
|
823
Barrett Business Services
BBSI
$800M
| $19.7M | 0.02% |
1,482,000
-144,400
| -9% | -$1.67M |
|
824
Village Super Market
VLGEA
$638M
| $19.7M | 0.02% |
709,885
+57,285
| +9% | +$1.38M |
|
825
The RMR Group
RMR
$346M
| $19.7M | 0.02% |
667,616
+16,900
| +3% | +$489K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.